Want to see ACHC full AI Analyst Report?
ACHC Stock Chart & Stats
$34.51
$0.50(1.47%)
At close: 4:00 PM EDT
$34.51
$0.50(1.47%)
Day’s Range― - ―
52-Week Range$11.43 - $35.83
Previous Close$34.51
Volume2.30M
Average Volume (3M)3.15M
Market Cap
$2.96B
Enterprise Value$5.30K
Total Cash (Recent Filing)$171.29M
Total Debt (Recent Filing)$2.56B
Price to Earnings (P/E)―
Beta0.65
Next Earnings
Nov 04, 2026EPS Estimate
0.48Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.45
Shares Outstanding93,100,270
10 Day Avg. Volume2,661,680
30 Day Avg. Volume3,151,765
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.66
Price to Sales (P/S)0.39
P/FCF Ratio-2.93
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$32.25Price Target Upside-6.55% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)1.53
Revenue Forecast (FY)$3.43B
Bulls Say, Bears Say
Bulls Say
Capacity Expansion & JV GrowthAccelerating bed additions and joint ventures expand scale and referral reach, diversifying revenue sources and lowering unit operating costs over time. Persistent capacity growth via JVs reduces single-site execution risk and supports sustainable top-line growth as new beds ramp to utilization.
Operating Cash Flow ImprovementConsistent positive operating cash flow demonstrates core services generate cash despite accounting losses. This strengthens the firm's ability to fund capex and start-ups, service debt and pursue JV builds without persistent external financing, improving medium-term financial resiliency.
Management Execution & Raised GuidanceUpward guidance after a quarter of outperformance signals operational leverage from cost efficiencies, better revenue per patient day and same-facility growth. Sustained execution can restore margins and credibility, aiding deleveraging and funding of strategic expansion over the next several quarters.
Bears Say
Major Legal Verdict RiskA large punitive verdict creates material legal and cash-flow uncertainty, likely prompting reserve increases or insurance disputes. Even if appealed, outcome risk and litigation costs can strain liquidity and credit metrics, complicating deleveraging and capital allocation for months.
Elevated LeverageHigher leverage limits financial flexibility to absorb shocks, fund start-ups, or pursue acquisitions. With net leverage near management's target range but timing-sensitive supplemental payments and earnings volatility, covenants, refinancing risk and interest burden remain medium-term constraints.
Weak Profitability & FCF ConversionA sharp swing to deep losses and negative FCF undermines intrinsic earnings power and increases reliance on external funding. Until same-facility margin recovery and FCF convertibility are sustained, capacity expansion and legal exposures could exacerbate cash strain and impede lasting recovery.
Acadia Healthcare News
ACHC FAQ
What was Acadia Healthcare’s price range in the past 12 months?
Acadia Healthcare lowest stock price was $11.43 and its highest was $35.83 in the past 12 months.
What is Acadia Healthcare’s market cap?
Acadia Healthcare’s market cap is $2.96B.
When is Acadia Healthcare’s upcoming earnings report date?
Acadia Healthcare’s upcoming earnings report date is Nov 04, 2026 which is in 83 days.
How were Acadia Healthcare’s earnings last quarter?
Acadia Healthcare released its earnings results on Jul 28, 2026. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.346 by $0.034.
Is Acadia Healthcare overvalued?
According to Wall Street analysts Acadia Healthcare’s price is currently Overvalued.
Does Acadia Healthcare pay dividends?
Acadia Healthcare does not currently pay dividends.
What is Acadia Healthcare’s EPS estimate?
Acadia Healthcare’s EPS estimate is 0.48.
How many shares outstanding does Acadia Healthcare have?
Acadia Healthcare has 93,100,270 shares outstanding.
What happened to Acadia Healthcare’s price movement after its last earnings report?
Acadia Healthcare reported an EPS of $0.38 in its last earnings report, beating expectations of $0.346. Following the earnings report the stock price went down -16.335%.
Which hedge fund is a major shareholder of Acadia Healthcare?
Currently, no hedge funds are holding shares in ACHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Acadia Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$32.25 (-6.55% Downside)
$32.25 (-6.55% Downside)
Blogger Sentiment
Bullish
ACHC Sentiment 75%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 4.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 10.8%
Last 30 Days ▼ 10.8%
Technicals
SMA
Positive
20 days / 200 days
Momentum
58.73%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-12.08%
Trailing 12-Months
Company Description
Acadia Healthcare
Acadia Healthcare Company, Inc. specializes in delivering a comprehensive range of behavioral health services, with its operations spanning the United States and Puerto Rico. Patients receive care in diverse environments, including acute inpatient psychiatric hospitals, specialized treatment facilities, long-term residential centers, and outpatient clinics. As of March 31, 2022, the company managed an extensive network consisting of 238 behavioral healthcare facilities, collectively providing approximately 10,600 beds. Established in 2005, Acadia Healthcare is headquartered in Franklin, Tennessee.
ACHC Company Deck
ACHC Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a constructive operational and financial start to 2026: revenue and adjusted EBITDA grew, results beat guidance, management raised full-year profitability targets, and execution initiatives (leadership changes, cost efficiencies, bed additions, JVs, technology) are showing early benefits. Offsetting these positives are persistent challenges in specialty (notably Pennsylvania), slower CTC performance due to weather, elevated bad debts/denials, temporary higher leverage in Q2 from timing of supplemental payments, and ongoing start-up/closure headwinds. Overall, progress on operations and margins appears to outweigh the headwinds, though some risks (payer behavior and supplemental approvals) remain.View all ACHC earnings summariesACHC Stock 12 Month Forecast
Average Price Target
$32.25
▼(-6.55% Downside)
Technical Analysis
Brookdale Senior Living
―
National Healthcare
―
―
Surgery Partners
―
Lifestance Health Group
―
Ownership Overview
2.18% Insiders
28.37% Mutual Funds
3.49% Other Institutional Investors
31.60% Public Companies and
Individual Investors